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to the subcarinal lymphadenopathy and
therefore received the full radiation dose
(Figure 2).
Most reports of unusual toxicities
after radiation therapy in patients with
collagen vascular diseases have been with
systemic lupus, rheumatoid arthritis, or
scleroderma.1 Behc¸et’s disease is a rare
condition characterized by the formation
of aphthous ulcers.2 Patients commonly
present with oral and genital ulcerations
but ulcers can develop in the gastrointes-
tinal tract, including the esophagus.2,3
Only one study has been published
reporting unusual toxicities in patients
with Behc¸et’s disease treated with radia-
tion therapy. Cengiz et al4 observed severe
late toxicity developing in 3 of 6 patients
treated with radiation therapy. A patient
with Hodgkin lymphoma developed bra-
chial plexopathy following 40 Gy to a
mantle field, a dose well below that ex-
pected to result in neurotoxicity. Another
patient developed ureteral stricture follow-
ing postoperative external beam radiation
therapy (50 Gy) for cervical cancer. Fi-
nally, a third patient developed skin necro-
sis after treatment of a malignant mesen-
chymal tumor (70 Gy).
Bronchoesophageal fistulas are rarely
seen in patients treated for lung cancer
with conventional doses of radiation ther-
apy. Oncologists treating patients with
Behc¸et’s disease should be aware of the
potential increased risk of normal tissue
toxicity and should consider screening for
esophageal ulcers before initiating treat-
ment for thoracic tumors.
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A 74-year-old man presented with
a cough and bloody sputum in 2005. He
had been treated curatively with radia-
tion for gastric mucosa associated lym-
phoid tissue (MALT) lymphoma in
2003 and had undergone endoscopic re-
section of an early gastric adenocarci-
noma in 2004. Computed tomography
revealed an ill-defined mass and two
small nodules with ground-glass opacity
in the left apicoposterior segment (Fig-
ure 1A). The mass was diagnosed as ad-
enocarcinoma on transbronchial biopsy
and a left upper lobectomy was per-
formed. Papillary adenocarcinoma was
confirmed (Figure 1B) and the mass was
considered a primary lung cancer because
of positive immunohistochemical staining
for surfactant protein A. The remaining
two lesions were diagnosed as MALT lym-
phoma (Figure 1C). Helicobacter pylori was
not found in either the pulmonary or gastric
MALT lymphoma. The polymerase chain
reaction analysis suggested that the lym-
phomas of both the lung and stomach
developed through a common mechanism,
API2-MALT1 (data not shown).
MALT lymphoma is caused by Hel-
icobacter pylori, autoimmune disease, and
genomic alternations such as the API2-
MALT1 gene.1 The synchronous occur-
rence of MALT lymphoma and adenocarci-
noma has often been documented in the
stomach and Helicobacter pylori seems to
be one of the common causes of both dis-
eases.2 To our knowledge, eight cases in-
cluding the present one, with simultaneous
lung cancer and pulmonary MALT lym-
phoma have been reported.3,4 The histology
of lung cancer was adenocarcinoma in seven
of the eight cases and MALT lymphoma
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FIGURE 1. (A) Chest computed tomography showing an ill-defined mass (arrow)
in the left apicoposterior segment and two nodules (arrowheads) adjacent to the
mass. (B) Hematoxylin-eosin staining of the papillary adenocarcinoma specimen.
The lesion is shown by the arrows in A. (C) Hematoxylin-eosin staining of the
MALT lymphoma. The lesion is shown by the arrowheads in A.
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developed close or adjacent to the adeno-
carcinoma in six. These facts suggest
some relationship between MALT lym-
phoma and adenocarcinoma of the lung.
The API2-MALT1 fusion gene
causes MALT lymphoma by activating
the nuclear factor-B and the subse-
quent antiapoptotic signaling.5 In our
case, the API2-MALT1 fusion gene or
factors associated with the gene might
have played a role in the development of
adenocarcinoma.
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ST Segment Elevation
and T Wave Inversion
on Electrocardiograms
2 Years after Surgery
for Lung Cancer
To the Editor:
ST segment elevation andT wave
inversion accompanied by abnormal Q
waves suggesting myocardial infarction
were found on an electrocardiogram
(ECG) in a 61-year-old woman (Figure 1).
The patient underwent surgery and received
adjuvant chemotherapy for a squamous cell
lung cancer 2 years prior. The ECG and
echocardiogram were normal before sur-
gery. The patient did not present with any
specific symptoms indicating ischemic heart
disease and the levels of the cardiac en-
zymes were not increased. A 2 4 cm sized
large mass was seen at the inferior and lat-
eral wall of the left ventricle on chest com-
puted tomography (CT) and echocardiogra-
phy. The tumor with low signal intensity
was also noted on a chest magnetic reso-
nance imaging (MRI) (Figure 2). A recur-
rence of lung cancer presenting with a
cardiac metastasis was highly suspected
although there was no other evidence of
malignancy. We recommended the ad-
ministration of anticoagulation therapy
with warfarin and regular follow-up as
the patient did not want further evalua-
tion and management at that time. A
chest CT obtained 6 months later revealed
that the cardiac mass was slight increased
and pericardial effusion with several lung
nodules had developed. In addition, the
patient complained of a 0.8 cm sized scalp
lesion and multiple skin nodules, which
were confirmed as metastatic squamous
cell carcinoma from a biopsy. 18FDG-
PET/CT depicted the hypermetabolic
mass of the heart with a standard uptake
value of 6.6, which could be differentiated
from a benign tumor or thrombus.
Lung cancer is one of the most
common cancers to metastasize to the
heart. However, proper diagnosis of
lung cancer that has metastasized to the
heart is difficult due to a lack of specific
symptoms and signs, especially when
the condition is the initial manifestation.
Echocardiography and chest CT have
been used to visualize intracardiac tu-
mors. Additional information such as
the relation between the tumor and myo-
cardium can be obtained thorough the
use of chest MRI.1 However, even with
the use of these modalities, it is often
difficult to differentiate an intracardiac
malignancy from diseases such as be-
nign tumors or a thrombus. As the signal
intensity of a thrombus on MRI varies
according to its age, identification of the
thrombus can be a diagnostic challenge
for clinicians.2 18FDG-FDG PET/CT may
be useful as in the present case as a throm-
bus usually does not accumulate FDG.3
Electrocardiographic (ECG) changes mim-
icking ischemic heart disease such as diffuse
ST elevation or T wave inversion can de-
velop. Cates et al. showed that new ECG
changes caused by a cardiac metastasis were
segmental (80%) or diffuse (10%) T wave
inversion and ST elevation (10%) mimick-
ing myocardial ischemia or injury.4 As the
number of elderly patients with lung
cancer is on the increase, the differenti-
ation of lung cancer from coronary ar-
tery disease is very important.5 Physi-
cians should be aware that any newly
developed ECG changes, especially if
suggestive of myocardial ischemia or
injury without appropriate symptoms,
not accompanied by elevated levels of
cardiac enzymes in patients with lung
cancer, might indicate the presence of a
cardiac metastasis.
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